Mskcc Renal Cell Carcinoma Risk Stratification

This health tool determines survival in the case of patient with metastatic renal cell carcinoma based on their clinical and laboratory data.

Mskcc renal cell carcinoma risk stratification.

He received the career development award from the national institutes of health and the schonfeld award from the kidney cancer association. It is appropriate for patients who have undergone either radical nephrectomy complete surgical removal of a kidney or partial nephrectomy surgical removal of the cancerous. The two scores of 5 respectively 7 items are the only clinical judgment tools that address survival of patients with metastatic renal cell carcinoma. Our renal cell carcinoma nomogram is an online tool that can be used to predict the likelihood that a patient s kidney cancer will not recur at five years after surgery following a new diagnosis.

If you are a patient we recommend that you use this tool in consultation with your. This nomogram was designed to be used by physicians and people with renal cell carcinoma. Motzer md is a medical oncologist at memorial sloan kettering cancer center. Our kidney cancer nomogram is a prediction tool designed to help patients and their physicians calculate the likely outcome of their surgical treatment for newly diagnosed renal cell carcinoma a type of kidney cancer.

It is based on the 670 patient original 1999 study by robert j motzer md at the memorial sloan kettering cancer center mskcc and is the most widely recognized prognostic algorithm for rcc.